The disclosed invention provides compositions and methods of treating a Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and a rhinovirus infection in a host, including animals, and especially humans, using a (2' R )-2'-deoxy-2'-fluoro-2'- C -methyl nucleosides, or a pharmaceutically acceptable salt or prodrug thereof.
